Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tyco Healthcare Looks To New Acquisitions After Splitting From Parent

This article was originally published in The Gray Sheet

Executive Summary

Tyco International maintains that its spin-off of Tyco Healthcare will allow the newly independent healthcare business to grow more rapidly

You may also be interested in...



Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco

Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International

Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco

Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International

Financings In Brief

Tyco Healthcare becomes Covidien: Device, diagnostic and drug manufacturer Tyco Healthcare spins off from parent firm Tyco International and is renamed Covidien, effective June 29. The firm begins independent trading on the New York Stock Exchange July 2 under the symbol COV. Tyco shareholders received one Covidien share for every four shares of the parent company held as of June 18. Generating nearly $10 billion in annual sales, Covidien's products include ventilators, sutures and surgical staplers, laparoscopic instruments, pulse oximetry devices, syringes, wound and incontinence care items and imaging agents. Key brands of the franchise include Autosuture, Devon, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture and Valleylab. Tyco's non-medical electronics business (Tyco Electronics) also will trade independently from the firm's remaining security/fire protection business (Tyco International) following the reorganization. Plans for the spin-offs, intended to give each of the units increased focus and flexibility, were first announced in January 2006. The newly independent entities will continue to be based in Bermuda (1"The Gray Sheet" Jan. 23, 2006, p. 11)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel